Live Breaking News & Updates on Greg zante

Stay updated with breaking news from Greg zante. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Concorde Asset Management LLC Buys 2,381 Shares of iShares Core Total USD Bond Market ETF (NASDAQ:IUSB)

Should You Buy or Sell Viking Therapeutics Stock? Get The Latest VKTX Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

San-diego , California , United-states , Switzerland , Blackrock , Swiss , Michaela-dinerman , Roth-mkm , Stifel-nicolaus , Greg-zante , Therapeutics-inc , Nasdaq

Greg Zante Sells 56,295 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) Stock

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) CFO Greg Zante sold 56,295 shares of the stock in a transaction on Tuesday, April 11th. The stock was sold at an average price of $18.00, for a total transaction of $1,013,310.00. Following the completion of the sale, the chief financial officer now directly owns 149,279 shares of […]

San-diego , California , United-states , Greg-zante , Raymond-james , Michaela-dinerman , Stifel-nicolaus , Roth-mkm , Steward-partners-investment-advisory , Schonfeld-strategic-advisors , Nasdaq , Therapeutics-company-profile

Viking Therapeutics (NASDAQ:VKTX) Hits New 12-Month High at $18.03

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) reached a new 52-week high on Tuesday . The company traded as high as $18.03 and last traded at $17.67, with a volume of 1964250 shares trading hands. The stock had previously closed at $16.94. Analyst Ratings Changes VKTX has been the topic of several recent research reports. […]

San-diego , California , United-states , Michaela-dinerman , Greg-zante , Stifel-nicolaus , Quantum-private-wealth , Summit-financial-wealth-advisors , Securities-exchange-commission , Cetera-advisor-networks , Maxim-group , Nasdaq

Insider Selling: Viking Therapeutics, Inc. (NASDAQ:VKTX) CFO Sells 131,029 Shares of Stock

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) CFO Greg Zante sold 131,029 shares of the business’s stock in a transaction that occurred on Thursday, March 30th. The shares were sold at an average price of $17.00, for a total value of $2,227,493.00. Following the completion of the transaction, the chief financial officer now owns 147,778 […]

San-diego , California , United-states , Blackrock , Roth-mkm , Greg-zante , Raymond-james , Michaela-dinerman , Therapeutics-inc , Nasdaq , Boxer-capital , Vanguard-group-inc

Greg Zante Sells 30,911 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) Stock

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) CFO Greg Zante sold 30,911 shares of the firm’s stock in a transaction on Monday, April 3rd. The stock was sold at an average price of $18.00, for a total transaction of $556,398.00. Following the completion of the sale, the chief financial officer now owns 147,778 shares in […]

San-diego , California , United-states , Michaela-dinerman , Greg-zante , Stifel-nicolaus , Roth-mkm , Nasdaq , Steward-partners-investment-advisory , Sg-americas-securities , Therapeutics-inc , Herr-investment-group

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2022 Earnings Call Transcript

Operator: Welcome to the Viking Therapeutics Fourth Quarter and Full-year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Greg-zante , Gregory-zante , Steven-seedhouse , Raymond-james , Joon-lee , Stephanie-diaz , Exchange-commission , Meeting-of-the-obesity-society , Therapeutics-inc , Nasdaq , Viking-therapeutics

Viking Therapeutics (VKTX) Q2 2021 Earnings Call Transcript


Operator
Welcome to the Viking Therapeutics' 2021 second-quarter financial results conference call. [Operator instructions] As a reminder, this conference call is being recorded today, July 28, 2021. I would now like to turn the conference over to Viking's manager of investor relations, Stephanie Diaz. Please go ahead, Stephanie.
Stephanie Diaz --
Manager of Investor Relations
Hello, and thank you all for participating in today's call. Joining me today is Brian Lian, Viking's president and CEO; and Greg Zante, Viking's CFO. Before we begin, I'd like to caution that comments made during this conference call today, July 28, 2021, will contain forward-looking statements under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including statements about Viking's expectations regarding its development activities, time lines and milestones.

Raymond-james , Joon-lee-truist , Greg-zante , Steven-seedhouse-raymond-james , Steven-seedhouse , Matthew-luchini , Joon-lee , Stephanie-diaz , Exchange-commission , International-liver-congress , Viking-therapeutics